Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1986 Jul;45(7):534–538. doi: 10.1136/ard.45.7.534

Immunogenetic heterogeneity of rheumatoid arthritis.

M L Westedt, F C Breedveld, G M Schreuder, J D'Amaro, A Cats, R R de Vries
PMCID: PMC1001933  PMID: 3488713

Abstract

Association of HLA-DR4/Dw4 with rheumatoid arthritis (RA) is well established, but conflicting data exist on a possible association with the severity of the disease, including its extra-articular manifestations. In order to investigate whether a subgroup of RA is preferentially associated with DR4, HLA typing was performed in two groups of patients with severe extra-articular manifestations (Felty's syndrome and histologically proved leucocytoclastic vasculitis), patients with severe joint destruction (seropositive and seronegative), a group with only mild joint destruction, and in healthy controls. The frequency of HLA-DR4 was significantly raised in all patient groups compared with that in healthy controls. The two groups with severe extra-articular manifestations, however, both had a DR4 frequency of 92%, which was significantly (p = 0.002) higher than the 62.7% found in the remaining patients. No significant differences were observed between severe or mild joint destruction and seropositivity or seronegativity in the groups without the above-mentioned extra-articular manifestations. From these data we concluded that DR4 is preferentially associated with severe extra-articular disease manifestations of RA. This observation provides an immunogenetic basis for the disease heterogeneity and for the immunological analogy between RA and leprosy.

Full text

PDF
538

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alarcón G. S., Koopman W. J., Acton R. T., Barger B. O. Seronegative rheumatoid arthritis. A distinct immunogenetic disease? Arthritis Rheum. 1982 May;25(5):502–507. doi: 10.1002/art.1780250503. [DOI] [PubMed] [Google Scholar]
  2. Bloom B. R., Godal T. Selective primary health care: strategies for control of disease in the developing world. V. Leprosy. Rev Infect Dis. 1983 Jul-Aug;5(4):765–780. doi: 10.1093/clinids/5.4.765. [DOI] [PubMed] [Google Scholar]
  3. Chalmers I. M. Ankylosing spondylitis in African Blacks. Arthritis Rheum. 1980 Dec;23(12):1366–1370. doi: 10.1002/art.1780231206. [DOI] [PubMed] [Google Scholar]
  4. Dobloug J. H., Førre O., Kåss E., Thorsby E. HLA antigens and rheumatoid arthritis. Association between HLA-DRw4 positivity and IgM rheumatoid factor production. Arthritis Rheum. 1980 Mar;23(3):309–313. doi: 10.1002/art.1780230307. [DOI] [PubMed] [Google Scholar]
  5. Holoshitz J., Naparstek Y., Ben-Nun A., Cohen I. R. Lines of T lymphocytes induce or vaccinate against autoimmune arthritis. Science. 1983 Jan 7;219(4580):56–58. doi: 10.1126/science.6336851. [DOI] [PubMed] [Google Scholar]
  6. Jaraquemada D., Pachoula-Papasteriadis C., Festenstein H., Sachs J. A., Roitt I. M., Corbett M., Ansell B. HLA-D and DR determinants in rheumatoid arthritis. Transplant Proc. 1979 Jun;11(2):1306–1306. [PubMed] [Google Scholar]
  7. Karsh J., Klippel J. H., Mann D. L., Reinertsen J. L., Moutsopoulos H. M., Johnson A. H., Decker J. L. Histocompatibility antigen combinations in rheumatoid arthritis. Clin Exp Rheumatol. 1983 Jan-Mar;1(1):11–15. [PubMed] [Google Scholar]
  8. Klein F., Bronsveld W., Norde W., Van Romunde L. K., Singer J. M. A modified latex-fixation test for the detection of rheumatoid factors. J Clin Pathol. 1979 Jan;32(1):90–92. doi: 10.1136/jcp.32.1.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. McMichael A. J., Sasazuki T., McDevitt H. O., Payne R. O. Increased frequency of HLA-Cw3 and HLA-Dw4 in rheumatoid arthritis. Arthritis Rheum. 1977 Jun;20(5):1037–1042. doi: 10.1002/art.1780200501. [DOI] [PubMed] [Google Scholar]
  10. Ollier W., Venables P. J., Mumford P. A., Maini R. N., Awad J., Jaraquemada D., D'Amaro J., Festenstein H. HLA antigen associations with extra-articular rheumatoid arthritis. Tissue Antigens. 1984 Nov;24(5):279–291. doi: 10.1111/j.1399-0039.1984.tb02139.x. [DOI] [PubMed] [Google Scholar]
  11. Panayi G. S. Does rheumatoid arthritis have a clinicopathological spectrum similar to that of leprosy? Ann Rheum Dis. 1982 Feb;41(1):102–103. doi: 10.1136/ard.41.1.102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Panayi G. S., Wooley P. H., Batchelor J. R. HLA-DRw4 and rheumatoid arthritis. Lancet. 1979 Mar 31;1(8118):730–730. doi: 10.1016/s0140-6736(79)91186-3. [DOI] [PubMed] [Google Scholar]
  13. ROPES M. W., BENNETT G. A., COBB S., JACOX R., JESSAR R. A. 1958 Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis. 1958 Dec;9(4):175–176. [PubMed] [Google Scholar]
  14. Scherak O., Smolen J. S., Mayr W. R. Rheumatoid arthritis and B lymphocyte alloantigen HLA-DRw4. J Rheumatol. 1980 Jan-Feb;7(1):9–12. [PubMed] [Google Scholar]
  15. Scott D. G., Bacon P. A., Tribe C. R. Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine (Baltimore) 1981 Jul;60(4):288–297. [PubMed] [Google Scholar]
  16. Stastny P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med. 1978 Apr 20;298(16):869–871. doi: 10.1056/NEJM197804202981602. [DOI] [PubMed] [Google Scholar]
  17. Svejgaard A., Jersild C., Nielsen L. S., Bodmer W. F. HL-A antigens and disease. Statistical and genetical considerations. Tissue Antigens. 1974;4(2):95–105. doi: 10.1111/j.1399-0039.1974.tb00230.x. [DOI] [PubMed] [Google Scholar]
  18. Walton K., Dyer P. A., Grennan D. M., Haeney M., Harris R. Clinical features, autoantibodies and HLA-DR antigens in rheumatoid arthritis. J Rheumatol. 1985 Apr;12(2):223–226. [PubMed] [Google Scholar]
  19. Westedt M. L., Herbrink P., Molenaar J. L., de Vries E., Verlaan P., Stijnen T., Cats A., Lindeman J. Rheumatoid factors in rheumatoid arthritis and vasculitis. Rheumatol Int. 1985;5(5):209–214. doi: 10.1007/BF00541338. [DOI] [PubMed] [Google Scholar]
  20. Young A., Jaraquemada D., Awad J., Festenstein H., Corbett M., Hay F. C., Roitt I. M. Association of HLA-DR4/Dw4 and DR2/Dw2 with radiologic changes in a prospective study of patients with rheumatoid arthritis. Preferential relationship with HLA-Dw rather than HLA-DR specificities. Arthritis Rheum. 1984 Jan;27(1):20–25. doi: 10.1002/art.1780270104. [DOI] [PubMed] [Google Scholar]
  21. de Jongh B. M., van Romunde L. K., Valkenburg H. A., de Lange G. G., van Rood J. J. Epidemiological study of HLA and GM in rheumatoid arthritis and related symptoms in an open Dutch population. Ann Rheum Dis. 1984 Aug;43(4):613–619. doi: 10.1136/ard.43.4.613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. de Vries R. R., Nijenhuis L. E., Khan M. A., Mehra N. K. Paradoxical inheritance of HLA-linked susceptibility to rheumatoid arthritis. Tissue Antigens. 1985 Nov;26(5):286–292. doi: 10.1111/j.1399-0039.1985.tb02226.x. [DOI] [PubMed] [Google Scholar]
  23. de Vries R. R., van Eden W., Ottenhoff T. H. HLA class-II immune response genes and products in leprosy. Prog Allergy. 1985;36:95–113. [PubMed] [Google Scholar]
  24. van Eden W., de Vries R. R. Occasional review--HLA and leprosy: a re-evaluation. Lepr Rev. 1984 Jun;55(2):89–104. doi: 10.5935/0305-7518.19840012. [DOI] [PubMed] [Google Scholar]
  25. van Rood J. J. HLA as regulator. Ann Rheum Dis. 1984 Oct;43(5):665–672. doi: 10.1136/ard.43.5.665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. van Rood J. J., van Leeuwen A., Ploem J. S. Simultaneous detection of two cell populations by two-colour fluorescence and application to the recognition of B-cell determinants. Nature. 1976 Aug 26;262(5571):795–797. doi: 10.1038/262795a0. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES